Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2012

Open Access 01-12-2012 | Research

Toxic epidermal necrolysis, DRESS, AGEP: Do overlap cases exist?

Authors: Sophie Bouvresse, Laurence Valeyrie-Allanore, Nicolas Ortonne, Marie Pauline Konstantinou, Sylvia H Kardaun, Martine Bagot, Pierre Wolkenstein, Jean-Claude Roujeau

Published in: Orphanet Journal of Rare Diseases | Issue 1/2012

Login to get access

Abstract

Background

Severe cutaneous adverse reactions to drugs (SCARs) include acute generalized exanthematous pustulosis (AGEP), drug reaction with eosinophilia and systemic symptoms (DRESS) and epidermal necrolysis (Stevens-Johnson syndrome–toxic epidermal necrolysis [SJS-TEN]). Because of the varied initial presentation of such adverse drug reactions, diagnosis may be difficult and suggests overlap among SCARs. Overlapping SCARs are defined as cases fulfilling the criteria for definite or probable diagnosis of at least 2 ADRs according to scoring systems for AGEP, DRESS and SJS-TEN. We aimed to evaluate the prevalence of overlap among SCARs among cases in the referral hospital in France.

Methods

We retrospectively analyzed data for 216 patients hospitalized in the referral centre over 7 years with a discharge diagnosis of AGEP (n = 45), DRESS (n = 47), SJS-TEN (n = 80) or “drug rash” (n = 44). Each case with detailed clinical data and a skin biopsy specimen was scored for AGEP, DRESS and SJS-TEN by use of diagnostic scores elaborated by the RegiSCAR group.

Results

In total, 45 of 216 cases (21%) had at least 2 possible diagnoses: 35 had a single predominant diagnosis (definite or probable), 7 had several possible diagnoses and 3 (2.1% of 145 confirmed SCARs) were overlap SCARs.

Conclusions

Despite ambiguities among SCARs, confirmed overlap cases are rare. This study did not avoid pitfalls linked to its retrospective nature and selection bias. In the acute stage of disease, early identification of severe ADRs can be difficult because of clinical or biologic overlapping features and missing data on histology, biology and evolution. Retrospectively analyzing cases by use of diagnostic algorithms can lead to reliable discrimination among AGEP, DRESS and SJS-TEN.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wolf R, Orion E, Marcos B, Matz H: Life-threatening acute adverse cutaneous drug reactions. Clin Dermatol. 2005, 23 (2): 171-181.CrossRefPubMed Wolf R, Orion E, Marcos B, Matz H: Life-threatening acute adverse cutaneous drug reactions. Clin Dermatol. 2005, 23 (2): 171-181.CrossRefPubMed
2.
go back to reference Roujeau JC, Stern RS: Severe adverse cutaneous reactions to drugs. N Engl J Med. 1994, 331 (19): 1272-1285. 10.1056/NEJM199411103311906.CrossRefPubMed Roujeau JC, Stern RS: Severe adverse cutaneous reactions to drugs. N Engl J Med. 1994, 331 (19): 1272-1285. 10.1056/NEJM199411103311906.CrossRefPubMed
3.
go back to reference Valeyrie-Allanore L, Sassolas B, Roujeau JC: Drug-induced skin, nail and hair disorders. Drug Saf. 2007, 30 (11): 1011-1030. 10.2165/00002018-200730110-00003.CrossRefPubMed Valeyrie-Allanore L, Sassolas B, Roujeau JC: Drug-induced skin, nail and hair disorders. Drug Saf. 2007, 30 (11): 1011-1030. 10.2165/00002018-200730110-00003.CrossRefPubMed
4.
go back to reference Sidoroff A, Halevy S, Bavinck JN, Vaillant L, Roujeau JC: Acute generalized exanthematous pustulosis (AGEP)-a clinical reaction pattern. J Cutan Pathol. 2001, 28 (3): 113-119. 10.1034/j.1600-0560.2001.028003113.x.CrossRefPubMed Sidoroff A, Halevy S, Bavinck JN, Vaillant L, Roujeau JC: Acute generalized exanthematous pustulosis (AGEP)-a clinical reaction pattern. J Cutan Pathol. 2001, 28 (3): 113-119. 10.1034/j.1600-0560.2001.028003113.x.CrossRefPubMed
5.
go back to reference Sidoroff A, Dunant A, Viboud C, et al: Risk factors for acute generalized exanthematous pustulosis (AGEP) – results of a multinational case–control study (EuroSCAR). Br J Dermatol. 2007, 157 (5): 989-996. 10.1111/j.1365-2133.2007.08156.x.CrossRefPubMed Sidoroff A, Dunant A, Viboud C, et al: Risk factors for acute generalized exanthematous pustulosis (AGEP) – results of a multinational case–control study (EuroSCAR). Br J Dermatol. 2007, 157 (5): 989-996. 10.1111/j.1365-2133.2007.08156.x.CrossRefPubMed
6.
go back to reference Bocquet H, Bagot M, Roujeau JC: Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg. 1996, 15 (4): 250-257. 10.1016/S1085-5629(96)80038-1.CrossRefPubMed Bocquet H, Bagot M, Roujeau JC: Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg. 1996, 15 (4): 250-257. 10.1016/S1085-5629(96)80038-1.CrossRefPubMed
7.
go back to reference Cacoub P, Musette P, Descamps V, et al: The DRESS syndrome: a literature review. Am J Med. 2011, 124 (7): 588-597. 10.1016/j.amjmed.2011.01.017.CrossRefPubMed Cacoub P, Musette P, Descamps V, et al: The DRESS syndrome: a literature review. Am J Med. 2011, 124 (7): 588-597. 10.1016/j.amjmed.2011.01.017.CrossRefPubMed
8.
go back to reference Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, Roujeau JC: Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?. Br J Dermatol. 2007, 156 (3): 609-611. 10.1111/j.1365-2133.2006.07704.x.CrossRefPubMed Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, Roujeau JC: Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?. Br J Dermatol. 2007, 156 (3): 609-611. 10.1111/j.1365-2133.2006.07704.x.CrossRefPubMed
9.
go back to reference Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schröder W, Roujeau JC, SCAR Study Group. Severe Cutaneous Adverse Reactions: Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol. 2002, 138 (8): 1019-1024. 10.1001/archderm.138.8.1019.CrossRefPubMed Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schröder W, Roujeau JC, SCAR Study Group. Severe Cutaneous Adverse Reactions: Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol. 2002, 138 (8): 1019-1024. 10.1001/archderm.138.8.1019.CrossRefPubMed
10.
go back to reference Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, Sidoroff A, Schneck J, Roujeau JC, Flahault A: Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol. 2008, 128 (1): 35-44. 10.1038/sj.jid.5701033.CrossRefPubMed Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, Sidoroff A, Schneck J, Roujeau JC, Flahault A: Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol. 2008, 128 (1): 35-44. 10.1038/sj.jid.5701033.CrossRefPubMed
11.
go back to reference Valeyrie-Allanore L, Poulalhon N, Fagot JP, Sekula P, Davidovici B, Sidoroff A, Mockenhaupt M: Stevens-Johnson syndrome and toxic epidermal necrolysis induced by amifostine during head and neck radiotherapy. Radiother Oncol. 2008, 87 (2): 300-303. 10.1016/j.radonc.2008.01.021.CrossRefPubMed Valeyrie-Allanore L, Poulalhon N, Fagot JP, Sekula P, Davidovici B, Sidoroff A, Mockenhaupt M: Stevens-Johnson syndrome and toxic epidermal necrolysis induced by amifostine during head and neck radiotherapy. Radiother Oncol. 2008, 87 (2): 300-303. 10.1016/j.radonc.2008.01.021.CrossRefPubMed
12.
go back to reference Roujeau JC, Bioulac-Sage P, Bourseau C, Guillaume JC, Bernard P, Lok C, Plantin P, Claudy A, Delavierre C, Vaillant L, Wechsler J, Danan G, Bénichou C, Beylot C: Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol. 1991, 127 (9): 1333-1338. 10.1001/archderm.1991.01680080069004.CrossRefPubMed Roujeau JC, Bioulac-Sage P, Bourseau C, Guillaume JC, Bernard P, Lok C, Plantin P, Claudy A, Delavierre C, Vaillant L, Wechsler J, Danan G, Bénichou C, Beylot C: Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol. 1991, 127 (9): 1333-1338. 10.1001/archderm.1991.01680080069004.CrossRefPubMed
13.
go back to reference Speeckaert MM, Speeckaert R, Lambert J, Brochez L: Acute generalized exanthematous pustulosis: an overview of the clinical, immunological and diagnostic concepts. Eur J Dermatol. 2010, 20 (4): 425-433.PubMed Speeckaert MM, Speeckaert R, Lambert J, Brochez L: Acute generalized exanthematous pustulosis: an overview of the clinical, immunological and diagnostic concepts. Eur J Dermatol. 2010, 20 (4): 425-433.PubMed
14.
go back to reference Peermohamed S, Haber RM: Acute generalized exanthematous pustulosis simulating toxic epidermal necrolysis: a case report and review of the literature. Arch Dermatol. 2011, 147 (6): 697-701. 10.1001/archdermatol.2011.147.CrossRefPubMed Peermohamed S, Haber RM: Acute generalized exanthematous pustulosis simulating toxic epidermal necrolysis: a case report and review of the literature. Arch Dermatol. 2011, 147 (6): 697-701. 10.1001/archdermatol.2011.147.CrossRefPubMed
15.
go back to reference Machet ML, Vaillant L: Acute generalized exanthematic pustulosis. Ann Dermatol Venereol. 2001, 128 (1): 73-79.PubMed Machet ML, Vaillant L: Acute generalized exanthematic pustulosis. Ann Dermatol Venereol. 2001, 128 (1): 73-79.PubMed
16.
go back to reference Kleier RS, Breneman DL, Boiko S: Generalized pustulation as a manifestation of the anticonvulsant hypersensitivity syndrome. Arch Dermatol. 1991, 127 (9): 1361-1364. 10.1001/archderm.1991.01680080097009.CrossRefPubMed Kleier RS, Breneman DL, Boiko S: Generalized pustulation as a manifestation of the anticonvulsant hypersensitivity syndrome. Arch Dermatol. 1991, 127 (9): 1361-1364. 10.1001/archderm.1991.01680080097009.CrossRefPubMed
17.
go back to reference Begon E, Roujeau JC: Drug hypersensitivity syndrome: DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms). Ann Dermatol Venereol. 2004, 131 (3): 293-297. 10.1016/S0151-9638(04)93600-9.CrossRefPubMed Begon E, Roujeau JC: Drug hypersensitivity syndrome: DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms). Ann Dermatol Venereol. 2004, 131 (3): 293-297. 10.1016/S0151-9638(04)93600-9.CrossRefPubMed
18.
go back to reference Wolf R, Davidovici B, Matz H, Mahlab K, Orion E, Sthoeger ZM: Drug Rash with eosinophilia and systemic symptoms versus Stevens-Johnson Syndrome–a case that indicates a stumbling block in the current classification. Int Arch Allergy Immunol. 2006, 141 (3): 308-310. 10.1159/000095437.CrossRefPubMed Wolf R, Davidovici B, Matz H, Mahlab K, Orion E, Sthoeger ZM: Drug Rash with eosinophilia and systemic symptoms versus Stevens-Johnson Syndrome–a case that indicates a stumbling block in the current classification. Int Arch Allergy Immunol. 2006, 141 (3): 308-310. 10.1159/000095437.CrossRefPubMed
19.
go back to reference Bombal C, Roujeau JC, Kuentz M, Revuz J, Touraine R: Hematologic anomalies in Lyell’s syndrome. Study of 26 cases. Ann Dermatol Venereol. 1983, 110 (2): 113-119.PubMed Bombal C, Roujeau JC, Kuentz M, Revuz J, Touraine R: Hematologic anomalies in Lyell’s syndrome. Study of 26 cases. Ann Dermatol Venereol. 1983, 110 (2): 113-119.PubMed
20.
go back to reference Lebargy F, Wolkenstein P, Gisselbrecht M, Lange F, Fleury-Feith J, Delclaux C, Roupie E, Revuz J, Roujeau JC: Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study. Intensive Care Med. 1997, 23 (12): 1237-1244. 10.1007/s001340050492.CrossRefPubMed Lebargy F, Wolkenstein P, Gisselbrecht M, Lange F, Fleury-Feith J, Delclaux C, Roupie E, Revuz J, Roujeau JC: Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study. Intensive Care Med. 1997, 23 (12): 1237-1244. 10.1007/s001340050492.CrossRefPubMed
21.
go back to reference Blum L, Chosidow O, Rostoker G, Philippon C, Revuz J, Roujeau JC: Renal involvement in toxic epidermal necrolysis. J Am Acad Dermatol. 1996, 34 (6): 1088-1090. 10.1016/S0190-9622(96)90297-2.CrossRefPubMed Blum L, Chosidow O, Rostoker G, Philippon C, Revuz J, Roujeau JC: Renal involvement in toxic epidermal necrolysis. J Am Acad Dermatol. 1996, 34 (6): 1088-1090. 10.1016/S0190-9622(96)90297-2.CrossRefPubMed
22.
go back to reference Valeyrie-Allanore L, Roujeau JC: Denominations and classification of severe cutaneous adverse reactions to drugs: splitters versus mergers. Eur J Dermatol. 2007, 17 (5): 359-360.PubMed Valeyrie-Allanore L, Roujeau JC: Denominations and classification of severe cutaneous adverse reactions to drugs: splitters versus mergers. Eur J Dermatol. 2007, 17 (5): 359-360.PubMed
23.
go back to reference Funck-Brentano E, Duong T, Family D, Bouaziz JD, Ortonne N, Bagot M, Roujeau JC, Wolkenstein P, Valeyrie-Allanore L: Auto-immune thyroiditis and drug reaction with eosinophilia and systemic symptoms (DRESS) associated with HHV-6 viral reactivation. Ann Dermatol Venereol. 2011, 138 (8–9): 580-585.CrossRefPubMed Funck-Brentano E, Duong T, Family D, Bouaziz JD, Ortonne N, Bagot M, Roujeau JC, Wolkenstein P, Valeyrie-Allanore L: Auto-immune thyroiditis and drug reaction with eosinophilia and systemic symptoms (DRESS) associated with HHV-6 viral reactivation. Ann Dermatol Venereol. 2011, 138 (8–9): 580-585.CrossRefPubMed
24.
go back to reference Geudry J, Roujeau JC, Binaghi M, Soubrane G, Muraine M: Risk factors for the development of ocular complications of Stevens–Johnson syndrome and toxic epidermal necrolysis. Arch Dermatol. 2009, 145 (2): 157-162. 10.1001/archdermatol.2009.540. Geudry J, Roujeau JC, Binaghi M, Soubrane G, Muraine M: Risk factors for the development of ocular complications of Stevens–Johnson syndrome and toxic epidermal necrolysis. Arch Dermatol. 2009, 145 (2): 157-162. 10.1001/archdermatol.2009.540.
25.
go back to reference Pichler WJ, Naisbitt DJ, Park BK: Immune pathomechanism of drug hypersensitivity reactions. J Allergy Clin Immunol. 2011, 127 (3): S74-S81. 10.1016/j.jaci.2010.11.048.CrossRefPubMed Pichler WJ, Naisbitt DJ, Park BK: Immune pathomechanism of drug hypersensitivity reactions. J Allergy Clin Immunol. 2011, 127 (3): S74-S81. 10.1016/j.jaci.2010.11.048.CrossRefPubMed
26.
go back to reference Pichler WJ, Adam J, Daubner B, Gentinetta T, Keller M, Yerly D: Drug hypersensitivity reactions: pathomechanism and clinical symptoms. Med Clin North Am. 2010, 94 (4): 645-664. 10.1016/j.mcna.2010.04.003.CrossRefPubMed Pichler WJ, Adam J, Daubner B, Gentinetta T, Keller M, Yerly D: Drug hypersensitivity reactions: pathomechanism and clinical symptoms. Med Clin North Am. 2010, 94 (4): 645-664. 10.1016/j.mcna.2010.04.003.CrossRefPubMed
27.
go back to reference Chung WH, Hung SI, Chen YT: Genetic predisposition of life-threatening antiepileptic-induced skin reactions. Expert Opin Drug Saf. 2010, 9 (1): 15-21. 10.1517/14740330903427969.CrossRefPubMed Chung WH, Hung SI, Chen YT: Genetic predisposition of life-threatening antiepileptic-induced skin reactions. Expert Opin Drug Saf. 2010, 9 (1): 15-21. 10.1517/14740330903427969.CrossRefPubMed
28.
go back to reference Picard D, Janela B, Descamps V, D’Incan M, Courville P, Jacquot S, Rogez S, Mardivirin L, Moins-Teisserenc H, Toubert A, Benichou J, Joly P, Musette P: Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response. Sci Transl Med. 2010, 2 (46): 46ra62-10.1126/scitranslmed.3001116.CrossRefPubMed Picard D, Janela B, Descamps V, D’Incan M, Courville P, Jacquot S, Rogez S, Mardivirin L, Moins-Teisserenc H, Toubert A, Benichou J, Joly P, Musette P: Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response. Sci Transl Med. 2010, 2 (46): 46ra62-10.1126/scitranslmed.3001116.CrossRefPubMed
29.
go back to reference Yawalkar N, Shrikhande M, Hari Y, Nievergelt H, Braathen LR, Pichler WJ: Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions. J Allergy Clin Immunol. 2000, 106 (6): 1171-1176. 10.1067/mai.2000.110922.CrossRefPubMed Yawalkar N, Shrikhande M, Hari Y, Nievergelt H, Braathen LR, Pichler WJ: Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions. J Allergy Clin Immunol. 2000, 106 (6): 1171-1176. 10.1067/mai.2000.110922.CrossRefPubMed
30.
go back to reference Britschgi M, Steiner UC, Schmid S, Depta JP, Senti G, Bircher A, Burkhart C, Yawalkar N, Pichler WJ: T-cell involvement in drug-induced acute generalized exanthematous pustulosis. J Clin Invest. 2001, 107 (11): 1433-1441. 10.1172/JCI12118.PubMedCentralCrossRefPubMed Britschgi M, Steiner UC, Schmid S, Depta JP, Senti G, Bircher A, Burkhart C, Yawalkar N, Pichler WJ: T-cell involvement in drug-induced acute generalized exanthematous pustulosis. J Clin Invest. 2001, 107 (11): 1433-1441. 10.1172/JCI12118.PubMedCentralCrossRefPubMed
31.
go back to reference Sugita K, Kabashima K, Sawada Y, Haruyama S, Yoshioka M, Mori T, Kobayashi M, Ogasawara K, Tokura Y: Increased circulating Th17 frequencies and serum IL-22 levels in patients with acute generalized exanthematous pustulosis. J Eur Acad Dermatol Venereol. 2011, 25 (4): 485-488. 10.1111/j.1468-3083.2010.03771.x.CrossRefPubMed Sugita K, Kabashima K, Sawada Y, Haruyama S, Yoshioka M, Mori T, Kobayashi M, Ogasawara K, Tokura Y: Increased circulating Th17 frequencies and serum IL-22 levels in patients with acute generalized exanthematous pustulosis. J Eur Acad Dermatol Venereol. 2011, 25 (4): 485-488. 10.1111/j.1468-3083.2010.03771.x.CrossRefPubMed
32.
33.
go back to reference Roujeau JC: Clinical heterogeneity of drug hypersensitivity. Toxicology. 2005, 209 (2): 123-129. 10.1016/j.tox.2004.12.022.CrossRefPubMed Roujeau JC: Clinical heterogeneity of drug hypersensitivity. Toxicology. 2005, 209 (2): 123-129. 10.1016/j.tox.2004.12.022.CrossRefPubMed
34.
go back to reference Hung SI, Chung WH, Jee SH, Chen WC, Chang YT, Lee WR, Hu SL, Wu MT, Chen GS, Wong TW, Hsiao PF, Chen WH, Shih HY, Fang WH, Wei CY, Lou YH, Huang YL, Lin JJ, Chen YT: Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenet Genomics. 2006, 16 (4): 297-306. 10.1097/01.fpc.0000199500.46842.4a.CrossRefPubMed Hung SI, Chung WH, Jee SH, Chen WC, Chang YT, Lee WR, Hu SL, Wu MT, Chen GS, Wong TW, Hsiao PF, Chen WH, Shih HY, Fang WH, Wei CY, Lou YH, Huang YL, Lin JJ, Chen YT: Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenet Genomics. 2006, 16 (4): 297-306. 10.1097/01.fpc.0000199500.46842.4a.CrossRefPubMed
Metadata
Title
Toxic epidermal necrolysis, DRESS, AGEP: Do overlap cases exist?
Authors
Sophie Bouvresse
Laurence Valeyrie-Allanore
Nicolas Ortonne
Marie Pauline Konstantinou
Sylvia H Kardaun
Martine Bagot
Pierre Wolkenstein
Jean-Claude Roujeau
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2012
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/1750-1172-7-72

Other articles of this Issue 1/2012

Orphanet Journal of Rare Diseases 1/2012 Go to the issue